Ca vulva, lymphatic drainage, lymph nodes, contralateral spread, squamous cell carcinoma, HPV-independent, HPV-dependent, DVIN, d-VIN, differentiated VIN, differentiated exophytic vulvar intraepithelial lesion (DEVIL), vulvar acanthosis with altered differentiation (VAAD), Vulvar SCC, HPV-associated, 2021 FIGO staging for carcinoma of the vulva, lymph node metastasis, radical local excision, microscopic tumor free margin, formalin fixed margin, groin management, groin LND, ipsilateral groin dissection, bilateral groin node dissection, inguinal and femoral nodes, sentinel lymph node assessment, local recurrence predictors, Heaps criteria, re-excision, radiotherapy, close or positive resection margin, unresectable, groin irradiation in LN positive disease, AGO-Care-1, adjuvant RT, radiosensitizing chemotherapy, weekly cisplatin, locally advanced inoperable vulvar cancer, neo-adjuvant chemo radiation, clinical CR, pathological CR, definitive chemoradiation, NACRT followed by surgery, overall treatment time (OTT), adjuvant radiation, target volume, inguinal LN, frog leg position, bolus, thermo-luminescent dosimeters, IMRT, OAR, SIB possible, PGI experience, 3DRT comparison, DRIVE Multicenter study, target volumes in locally advanced vulvar cancer